Mortality and deciding factors for no revascularization in cardiogenic shock patients; a cross sectional study

Zohaib Akhter1, Sajid Hussain1, Saba Aijaz1

  • 1Tabba Heart Institute, Karachi, Pakistan.

Insights

Acute coronary syndrome patients with cardiogenic shock not receiving revascularization had a high in-hospital mortality rate of 81.8%. Many patients died before or during the revascularization process, with common reasons for non-treatment including cardiac arrest and multi-organ failure.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Clinical Research

Background:

  • Acute coronary syndrome (ACS) can precipitate cardiogenic shock (CS), a life-threatening condition.
  • Revascularization is a cornerstone in managing ACS, but its role in CS is complex.
  • Understanding outcomes and decision-making for ACS patients with CS who do not receive revascularization is crucial.

Observation:

  • A retrospective study analyzed 383 ACS patients with hypotension, identifying 55 (14.3%) who did not undergo revascularization.
  • The in-hospital mortality rate for this subgroup was high at 81.8%.
  • Among those intended for revascularization, a significant proportion died before or after cardiac catheterization but before the procedure.

Findings:

  • Common reasons for not considering revascularization included hypoxic brain injury post-cardiac arrest, patient refusal, frailty, multi-organ failure, sepsis, or pre-existing conditions.
  • In many cases (two-thirds), cardiac arrest occurred before treatment initiation, with failed resuscitation or poor recovery.
  • The study highlights a very poor early outcome for cardiogenic shock complicating myocardial infarction when revascularization is not performed.

Implications:

  • These findings underscore the critical condition of ACS patients with CS who are not revascularized.
  • The data suggests a need for improved risk stratification and timely management decisions in this high-mortality group.
  • Further research may explore alternative or optimized treatment strategies for non-revascularized CS patients.
Abstract

Related Concept Videos